Drug Shortage Report for APO-AMOXI
Report ID | 177129 |
Drug Identification Number | 00628115 |
Brand name | APO-AMOXI |
Common or Proper name | AMOXICILLAN |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | AMOXICILLIN |
Strength(s) | 250MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL |
ATC code | J01CA |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-12-01 |
Estimated end date | 2023-06-23 |
Actual end date | 2023-04-13 |
Shortage status | Resolved |
Updated date | 2023-04-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-12-05 | English | Compare |
v2 | 2022-12-05 | French | Compare |
v3 | 2022-12-23 | English | Compare |
v4 | 2022-12-23 | French | Compare |
v5 | 2023-02-16 | English | Compare |
v6 | 2023-02-16 | English | Compare |
v7 | 2023-02-16 | French | Compare |
v8 | 2023-04-14 | English | Compare |
v9 | 2023-04-14 | French | Compare |
Showing 1 to 9 of 9